文献速递糖尿病

1型糖尿病患者的睡眠障碍与心血管风险缓解

Sleep Disturbances in Type 1 Diabetes and Mitigating Cardiovascular Risk.
PubMed 文献 · J Clin Endocrinol Metab · 2024-01-01

本文综述1型糖尿病患者睡眠障碍与心血管疾病的关系,探讨血糖控制、血压、脂代谢、体重管理、压力和自我护理行为等可能中介因素,并提及早期小规模研究显示睡眠干预可缓解心血管风险因素,建议将睡眠评估纳入常规管理。

要点

  • 1型糖尿病患者常存在睡眠障碍,睡眠已被视为心血管风险因素。
  • 睡眠障碍与心血管疾病关联的可能中介包括血糖控制、血压、脂代谢和体重管理。
  • 早期小规模研究显示睡眠干预可能缓解1型糖尿病的心血管风险因素。

核心结论

  • 睡眠评估应成为1型糖尿病患者标准诊疗的一部分。
  • 进一步研究应聚焦睡眠障碍对心血管风险的影响和机制通路,并开发1型糖尿病特异性睡眠干预以减轻心血管疾病负担。

研究设计与样本

  • 综述,全面探讨1型糖尿病中睡眠障碍与心血管疾病的关系。

主要发现

  • 大量证据提示1型糖尿病患者常遭遇睡眠障碍。
  • 血糖控制作为睡眠障碍与心血管疾病之间可能的中介已被较广泛研究,血压、脂代谢和体重管理作为中介研究较少。
  • 压力和自我护理行为也可能在睡眠障碍与心血管疾病的关系中起作用。
  • 近期早期小规模研究显示了1型糖尿病背景下睡眠干预在缓解心血管风险因素方面的证据。

临床怎么用

  • 作者认为睡眠评估应成为1型糖尿病患者标准诊疗的一部分。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cardiovascular disease (CVD) is a major cause of morbidity and mortality in persons with type 1 diabetes (T1D). Despite control of known cardiovascular (CV) risk factors and better glycemic management, persons with T1D still face heightened CVD risk, suggesting additional contributing factors. Sleep has recently been recognized as a CV risk factor; however; the role of sleep in CVD specifically in T1D population has only started to emerge. Extensive evidence suggests that persons with T1D often encounter sleep disturbances. This review aims to comprehensively explore the relationship between sleep disturbances and CVD in T1D, proposed possible mediators including glycemic control, which has been studied more extensively, and less studied factors such as blood pressure, lipid metabolism, and weight management. Stress and self-care behaviors likely also play a role in the relationship between sleep disturbances and CVD. The evidence regarding sleep interventions in the context of T1D in mitigating these CV risk factors has recently been shown in early, small-scale studies. Sleep assessments should be a part of the standard of care in persons with T1D. Further research should focus on understanding the impact and mechanistic pathways of sleep disturbances on CV risk and developing T1D-specific sleep interventions to reduce CVD burden in this population.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Abu Irsheed G, Martyn-Nemeth P, Baron KG, et al. Sleep Disturbances in Type 1 Diabetes and Mitigating Cardiovascular Risk. J Clin Endocrinol Metab. 2024. PMID: 39106222. doi:10.1210/clinem/dgae539

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。